Trademark/Service Mark Application, Principal Register
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Genzyme Corporation
*MAILING ADDRESS
50 Binney Street
*CITY
Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02142
*EMAIL ADDRESS
XXXX
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION
Massachusetts
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system;
pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and
autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
FILING BASIS
SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
SIGNIFICANCE OF MARK
ZELRAYMI appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in
connection with the goods/services listed in the application, or any geographical significance.
ATTORNEY INFORMATION
NAME
Karen Lim
ATTORNEY DOCKET NUMBER
GENZ 2102761
ATTORNEY BAR MEMBERSHIP NUMBER
XXX
YEAR OF ADMISSION
XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY
XX
FIRM NAME
Fross Zelnick Lehrman & Zissu, P.C.
STREET
151 West 42nd St., 17th Fl.
CITY
New York
STATE
New York
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United States
ZIP/POSTAL CODE
10036
EMAIL ADDRESS
klim-docket@fzlz.com
OTHER APPOINTED ATTORNEY
Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Nancy Sabarra, Charles T.J. Weigell, Ashford Tucker, Tamar Niv
Bessinger
CORRESPONDENCE INFORMATION
NAME
Karen Lim
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE
klim-docket@fzlz.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES)
NOT PROVIDED
FEE INFORMATION
APPLICATION FILING OPTION
TEAS Standard
NUMBER OF CLASSES
1
APPLICATION FOR REGISTRATION PER CLASS
350
*TOTAL FEES DUE
350
*TOTAL FEES PAID
350
SIGNATURE INFORMATION
SIGNATURE
/caroline casalonga/
SIGNATORY'S NAME
CASALONGA Caroline
SIGNATORY'S POSITION
Authorized Signatory pursuant to a Power of Attorney
DATE SIGNED
02/17/2021
SIGNATURE METHOD
Sent to third party for signature
PTO- 1478
Approved for use through 02/28/2021. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number
Trademark/Service Mark Application, Principal Register
Serial Number:90531821
Filing Date:02/17/2021
To the Commissioner for Trademarks:
MARK: ZELRAYMI (Standard Characters, see mark)
The literal element of the mark consists of ZELRAYMI. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Genzyme Corporation, a corporation of Massachusetts, having an address of
50 Binney Street
Cambridge, Massachusetts 02142
United States
XXXX
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the
treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney
disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
Significance of wording, letter(s), or numeral(s)
ZELRAYMI appearing in the mark has no significance nor is it a term of art in the relevant trade or industry or as used in connection with the goods/services listed in the application, or any
geographical significance.
The owner's/holder's proposed attorney information: Karen Lim. Other appointed attorneys are Lawrence E. Apolzon, Andrew N. Fredbeck, Allison Strickland Ricketts, Nancy Sabarra, Charles T.J. Weigell,
Ashford Tucker, Tamar Niv Bessinger. Karen Lim of Fross Zelnick Lehrman & Zissu, P.C., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is
located at
151 West 42nd St., 17th Fl.
New York, New York 10036
United States
klim-docket@fzlz.com
The docket/reference number is GENZ 2102761.
Karen Lim submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S.
Commonwealth or territory.
The applicant's current Correspondence Information:
Karen Lim
PRIMARY EMAIL FOR CORRESPONDENCE: klim-docket@fzlz.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /caroline casalonga/ Date: 02/17/2021
Signatory's Name: CASALONGA Caroline
Signatory's Position: Authorized Signatory pursuant to a Power of Attorney
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 90531821
Payment Accounting Date: 02/17/2021
Serial Number: 90531821
Internet Transmission Date: Wed Feb 17 11:53:32 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XX-2021021711533229
5248-90531821-770969b6b91ec2cf07d8c559cd
6668b16ac6306a44a12c5e16dc6ac14f82a1816-
DA-53323566-20210216150000436104